The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel

Objective: Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its seventh meeting (August 2016), the main objective was to discuss tramadol’s role in treating pain in Latin America. Furthermore, p...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2017
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23815
Acceso en línea:
https://doi.org/10.1080/03007995.2017.1354821
https://repository.urosario.edu.co/handle/10336/23815
Palabra clave:
Nonsteroid antiinflammatory agent
Opiate
Tramadol
Narcotic analgesic agent
Nonsteroid antiinflammatory agent
Tramadol
Cancer pain
Cardiovascular disease
Central america
Chronic pain
Constipation
Disease severity
Drug abuse
Drug dependence
Drug efficacy
Drug indication
Drug safety
Drug tolerability
Fibromyalgia
Gastrointestinal symptom
Health care quality
Human
Musculoskeletal pain
Nausea
Nephrotoxicity
Pain
Postoperative pain
Posttraumatic pain
Randomized controlled trial (topic)
Respiration depression
Review
Side effect
South america
Vomiting
Aged
Analgesia
South and central america
Aged
Cancer pain
Chronic pain
Humans
Latin america
Pain management
Tramadol
Abuse
Latin america
Pain management
Prescription control
Tramadol
non-steroidal
opioid
Analgesics
Anti-inflammatory agents
Rights
License
Abierto (Texto Completo)
id EDOCUR2_bfbe54fcaac15b7fb93ac5fe6b1b8ea7
oai_identifier_str oai:repository.urosario.edu.co:10336/23815
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
dc.title.spa.fl_str_mv The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel
title The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel
spellingShingle The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel
Nonsteroid antiinflammatory agent
Opiate
Tramadol
Narcotic analgesic agent
Nonsteroid antiinflammatory agent
Tramadol
Cancer pain
Cardiovascular disease
Central america
Chronic pain
Constipation
Disease severity
Drug abuse
Drug dependence
Drug efficacy
Drug indication
Drug safety
Drug tolerability
Fibromyalgia
Gastrointestinal symptom
Health care quality
Human
Musculoskeletal pain
Nausea
Nephrotoxicity
Pain
Postoperative pain
Posttraumatic pain
Randomized controlled trial (topic)
Respiration depression
Review
Side effect
South america
Vomiting
Aged
Analgesia
South and central america
Aged
Cancer pain
Chronic pain
Humans
Latin america
Pain management
Tramadol
Abuse
Latin america
Pain management
Prescription control
Tramadol
non-steroidal
opioid
Analgesics
Anti-inflammatory agents
title_short The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel
title_full The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel
title_fullStr The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel
title_full_unstemmed The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel
title_sort The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel
dc.subject.keyword.spa.fl_str_mv Nonsteroid antiinflammatory agent
Opiate
Tramadol
Narcotic analgesic agent
Nonsteroid antiinflammatory agent
Tramadol
Cancer pain
Cardiovascular disease
Central america
Chronic pain
Constipation
Disease severity
Drug abuse
Drug dependence
Drug efficacy
Drug indication
Drug safety
Drug tolerability
Fibromyalgia
Gastrointestinal symptom
Health care quality
Human
Musculoskeletal pain
Nausea
Nephrotoxicity
Pain
Postoperative pain
Posttraumatic pain
Randomized controlled trial (topic)
Respiration depression
Review
Side effect
South america
Vomiting
Aged
Analgesia
South and central america
Aged
Cancer pain
Chronic pain
Humans
Latin america
Pain management
Tramadol
Abuse
Latin america
Pain management
Prescription control
Tramadol
topic Nonsteroid antiinflammatory agent
Opiate
Tramadol
Narcotic analgesic agent
Nonsteroid antiinflammatory agent
Tramadol
Cancer pain
Cardiovascular disease
Central america
Chronic pain
Constipation
Disease severity
Drug abuse
Drug dependence
Drug efficacy
Drug indication
Drug safety
Drug tolerability
Fibromyalgia
Gastrointestinal symptom
Health care quality
Human
Musculoskeletal pain
Nausea
Nephrotoxicity
Pain
Postoperative pain
Posttraumatic pain
Randomized controlled trial (topic)
Respiration depression
Review
Side effect
South america
Vomiting
Aged
Analgesia
South and central america
Aged
Cancer pain
Chronic pain
Humans
Latin america
Pain management
Tramadol
Abuse
Latin america
Pain management
Prescription control
Tramadol
non-steroidal
opioid
Analgesics
Anti-inflammatory agents
dc.subject.keyword.eng.fl_str_mv non-steroidal
opioid
Analgesics
Anti-inflammatory agents
description Objective: Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its seventh meeting (August 2016), the main objective was to discuss tramadol’s role in treating pain in Latin America. Furthermore, potential pain management consequences were considered, if tramadol was to become more stringently controlled. Methods: Key topics discussed were: main indications for prescribing tramadol, its pharmacological characteristics, safety and tolerability, effects of restrictions on its availability and use, and consequent impact on pain care quality. Results: The experts agreed that tramadol is used to treat a wide spectrum of non-oncological pain conditions (e.g. post-surgical, musculoskeletal, post-traumatic, neuropathic, fibromyalgia), as well as cancer pain. Its relevance when treating special patient groups (e.g. the elderly) is recognized. The main reasons for tramadol’s high significance as a treatment option are: its broad efficacy, an inconspicuous safety profile and its availability, considering that access to strong analgesics–mainly controlled drugs (classical opioids)–is highly restricted in some countries. The CPLA also agreed that tramadol is well tolerated, without the safety issues associated with long-term nonsteroidal anti-inflammatory drug (NSAID) use, with fewer opioid-like side effects than classical opioids and lower abuse risk. Conclusions: In Latin America, tramadol is a valuable and frequently used medication for treating moderate to severe pain. More stringent regulations would have significant impact on its availability, especially for outpatients. This could cause regression to older and frequently inadequate pain management methods, resulting in unnecessary suffering for many Latin American patients. © 2017 Informa UK Limited, trading as Taylor and Francis Group.
publishDate 2017
dc.date.created.spa.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:05:40Z
dc.date.available.none.fl_str_mv 2020-05-26T00:05:40Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1080/03007995.2017.1354821
dc.identifier.issn.none.fl_str_mv 3007995
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23815
url https://doi.org/10.1080/03007995.2017.1354821
https://repository.urosario.edu.co/handle/10336/23815
identifier_str_mv 3007995
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 1621
dc.relation.citationIssue.none.fl_str_mv No. 9
dc.relation.citationStartPage.none.fl_str_mv 1615
dc.relation.citationTitle.none.fl_str_mv Current Medical Research and Opinion
dc.relation.citationVolume.none.fl_str_mv Vol. 33
dc.relation.ispartof.spa.fl_str_mv Current Medical Research and Opinion, ISSN:3007995, Vol.33, No.9 (2017); pp. 1615-1621
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027699710&doi=10.1080%2f03007995.2017.1354821&partnerID=40&md5=6d93f117df15722fb10b85cc88e5fa56
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Taylor and Francis Ltd
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167648109330432
spelling b327f855-0083-4db5-b9cf-1a849496e27b-149c35e73-e415-46ef-af65-8d0e2a16dc73-1f4498f80-b3b6-4614-90ff-bd3bb9910207-1bb5f482f-cfbc-47d5-a6a6-bee244a0bda2-16d8e2c70-71e3-497f-b3f5-a50500d3a5ec-19a2e77bd-ac48-4472-8ee9-2e485379bb48-1076c0a18-dc60-463a-b429-32109206fc6c-1707abfde-ca64-45e7-8c76-a7b31beb9cef-1ec793379-46be-489c-ab83-cdcb16d668ee-1844f616a-bb06-4abb-ae8b-44a368a57e6d-15351dfd4-4bc6-4016-89e6-377cc976ab0a-1f0e13369-062b-4f9f-8adf-88ad4cd2479a-18ff0c7f7-f530-4f0e-894e-f8af975c0f39-138f62a84-ca58-4aff-84d4-b9e82fbc9903-13cb6e085-ed62-4b53-95db-1e819a9e5f97-12020-05-26T00:05:40Z2020-05-26T00:05:40Z2017Objective: Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its seventh meeting (August 2016), the main objective was to discuss tramadol’s role in treating pain in Latin America. Furthermore, potential pain management consequences were considered, if tramadol was to become more stringently controlled. Methods: Key topics discussed were: main indications for prescribing tramadol, its pharmacological characteristics, safety and tolerability, effects of restrictions on its availability and use, and consequent impact on pain care quality. Results: The experts agreed that tramadol is used to treat a wide spectrum of non-oncological pain conditions (e.g. post-surgical, musculoskeletal, post-traumatic, neuropathic, fibromyalgia), as well as cancer pain. Its relevance when treating special patient groups (e.g. the elderly) is recognized. The main reasons for tramadol’s high significance as a treatment option are: its broad efficacy, an inconspicuous safety profile and its availability, considering that access to strong analgesics–mainly controlled drugs (classical opioids)–is highly restricted in some countries. The CPLA also agreed that tramadol is well tolerated, without the safety issues associated with long-term nonsteroidal anti-inflammatory drug (NSAID) use, with fewer opioid-like side effects than classical opioids and lower abuse risk. Conclusions: In Latin America, tramadol is a valuable and frequently used medication for treating moderate to severe pain. More stringent regulations would have significant impact on its availability, especially for outpatients. This could cause regression to older and frequently inadequate pain management methods, resulting in unnecessary suffering for many Latin American patients. © 2017 Informa UK Limited, trading as Taylor and Francis Group.application/pdfhttps://doi.org/10.1080/03007995.2017.13548213007995https://repository.urosario.edu.co/handle/10336/23815engTaylor and Francis Ltd1621No. 91615Current Medical Research and OpinionVol. 33Current Medical Research and Opinion, ISSN:3007995, Vol.33, No.9 (2017); pp. 1615-1621https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027699710&doi=10.1080%2f03007995.2017.1354821&partnerID=40&md5=6d93f117df15722fb10b85cc88e5fa56Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURNonsteroid antiinflammatory agentOpiateTramadolNarcotic analgesic agentNonsteroid antiinflammatory agentTramadolCancer painCardiovascular diseaseCentral americaChronic painConstipationDisease severityDrug abuseDrug dependenceDrug efficacyDrug indicationDrug safetyDrug tolerabilityFibromyalgiaGastrointestinal symptomHealth care qualityHumanMusculoskeletal painNauseaNephrotoxicityPainPostoperative painPosttraumatic painRandomized controlled trial (topic)Respiration depressionReviewSide effectSouth americaVomitingAgedAnalgesiaSouth and central americaAgedCancer painChronic painHumansLatin americaPain managementTramadolAbuseLatin americaPain managementPrescription controlTramadolnon-steroidalopioidAnalgesicsAnti-inflammatory agentsThe role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory PanelarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Santos Garcia J.B.Lech O.Campos Kraychete D.Rico M.A.Hernández-Castro J.J.Colimon F.Guerrero C.Sempértegui Gallegos M.Lara-Solares A.Flores Cantisani J.A.Amescua-Garcia C.Guillén Núñez M.D.R.Berenguel Cook M.D.R.Jreige Iskandar A.Bonilla Sierra P.10336/23815oai:repository.urosario.edu.co:10336/238152022-05-02 07:37:14.682426https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co